Company record
CH3 BioSystems, LLC develops and supplies biotechnology products, including polyclonal antibodies, enzyme inhibitors, and custom‑synthesized peptides. Its portfolio is targeted toward research and therapeutic projects addressing cancer, autoimmune disorders, neurodevelopmental conditions, viral infections, and cardiovascular diseases.
This directory record does not yet have a linked material-flow brief.